Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability
Record Year with Key Partnerships, Global Expansion and Expanded Top Talent
"At Flagship, we focus on pioneering original science, and on harnessing the ingenuity needed to invent transformative technologies and companies that improve human health as well as the sustainability of our planet," said
"Over the past six years, Flagship has also pioneered AI-enabled platforms that transform drug discovery, speed up the drug development process and gain new insights into human health and sustainability," Afeyan added. "By leveraging the power and potential of generative AI, we're embracing a future in which companies are created and expanded in ways we have not previously experienced, with the prospect for unprecedented impact."
Financial Update
With its latest raise, Flagship is now operating with an aggregate capital pool of
"Flagship Fund VIII is backed by a diverse group of investors globally – both new and longstanding Limited Partners – and we are grateful for their support of the work we do to create breakthrough innovations that address some of the world's most critical challenges," Afeyan continued. "This expanded capital pool will enable us to drive scientific discovery, with a portfolio that reflects a compelling combination of platforms, products, and impact. This capital will greatly fuel our origination activities and accelerate value creation from our transformational companies."
Partnering to Scale Innovation and Impact
Flagship's unique approach to pioneering science and to breakthrough biotech platforms has led to several novel partnerships within the pharmaceutical industry and beyond. In the past year, Flagship announced strategic partnerships with Pfizer, Samsung, and Thermo Fisher Scientific, in addition to reaching several partnership milestones with Novo Nordisk.
Underpinning these partnerships is Flagship's
"Partnerships have long been core to Flagship's strategy for maximizing value creation and the impact of our companies," Afeyan said. "Through these most recent alliances, and others under development, Flagship is leveraging the distinctive capabilities of our partners to significantly enhance and facilitate our product development capabilities as well as commercialize our innovations at scale."
Over the last three years, Pioneering Medicines, Flagship's in house drug development unit which leads its current partnerships with Pfizer, Novo Nordisk, and the
Expanding Flagship's Global Footprint
At the end of 2023, Flagship expanded into the
Flagship's expansion into APAC, focused on serving
Assembling Top Talent
Flagship is dedicated to hiring and nurturing world-class executives with a history of extraordinary performance, as illustrated by the company's recent hires and promotions
in the past year
. These include
About Flagship Pioneering
Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than
Media Contact:
ooffner@flagshippioneering.com
Investor Contact:
Andre Jabban
ajabban@flagshippioneering.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/flagship-pioneering-raises-3-6-billion-to-fuel-breakthrough-innovations-that-transform-human-health-and-sustainability-302192743.html
SOURCE Flagship Pioneering